Dermatomyositis+1
RecruitingStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
- Disease:DermatomyositisPolymyositis
- Substances:Anifrolumab
Denmark- Participants:18–64 years · 65+ years
- Substances:Anifrolumab
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Denmark482 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.
Trials aim to assess innovative treatments and monitor long-term disease control.
Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.
Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.
Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.
Trials assess both established and experimental therapies for inflammatory conditions.
Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.
Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.